
|Articles|January 15, 2005
FDA Approves Macugen
The FDA approved pegaptanib sodium injection (Macugen, Eyetech Pharmaceuticals and Pfizer Ophthalmics) for the treatment of neovascular age-related macular degeneration (AMD) on Dec. 17.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement

















